Jigar Mistry of Buoyant Capital favors healthcare, materials, chemicals, and banking sectors, preferring large-cap private banks over PSU banks. He remains positive on both generic and CDMO pharma segments, dismissing tariff concerns. Mistry believes valuations are elevated, especially for narrative-driven stocks lacking earnings, advocating for a focus on fundamentals over market flows.
FPIs bet small on local debt, inflow pickup seen far away
April witnessed a slight inflow of foreign investments into Indian debt, but the atmosphere remains one of caution. Influences like escalating US and Japan interest
May 2, 2026